Regulation of D-cyclin translation inhibition in myeloma cells treated with mammalian target of rapamycin inhibitors: rationale for combined treatment with extracellular signal-regulated kinase inhibitors and rapamycin.
about
Cap-Independent Translation in Hematological MalignanciesRapamycin protects mice from staphylococcal enterotoxin B-induced toxic shock and blocks cytokine release in vitro and in vivo.Targeting TORC2 in multiple myeloma with a new mTOR kinase inhibitor.Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortiumTranslational control of cyclins.Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group study.Synergistic combinations of signaling pathway inhibitors: mechanisms for improved cancer therapy.Exploring mammalian target of rapamycin (mTOR) inhibition for treatment of mantle cell lymphoma and other hematologic malignancies.Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies.The mammalian target of rapamycin pathway as a therapeutic target in multiple myeloma.Utility of mTOR inhibition in hematologic malignancies.Cytoplasmic RNA-binding proteins and the control of complex brain function.Emerging pathways as individualized therapeutic target of multiple myeloma.A DNA-binding Molecule Targeting the Adaptive Hypoxic Response in Multiple Myeloma Has Potent Antitumor Activity.MNK kinases facilitate c-myc IRES activity in rapamycin-treated multiple myeloma cellsHIF-1α and rapamycin act as gerosuppressant in multiple myeloma cells upon genotoxic stress.Mammalian target of rapamycin inhibitors induce tumor cell apoptosis in vivo primarily by inhibiting VEGF expression and angiogenesis.Restoration of the prolyl-hydroxylase domain protein-3 oxygen-sensing mechanism is responsible for regulation of HIF2α expression and induction of sensitivity of myeloma cells to hypoxia-mediated apoptosis.Post-autologous transplant maintenance therapies in lymphoma: current state and future directions.The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2.
P2860
Q26770568-8B820099-B3C5-48F4-AC1F-70F961AF5944Q33676236-2376B741-6534-4C2D-91AA-BD6700CF5784Q34374071-834DEDA9-33D3-4576-8956-4D6F85E35558Q34488779-7CF64DD9-65ED-4549-8F5C-FB5D8EBD7A69Q34623222-B5791834-1469-47CA-BB53-66B003378D92Q35913613-6096BD4A-C3DD-4D5A-9EE6-CB70B9575044Q37227994-BE335702-F196-48F2-80E6-8CAB3A5107B7Q37598141-2B6C4A87-EFBC-4B01-808D-33F284FC459FQ37779489-4C17A1F7-31EF-4B1D-9E8F-49590905F43AQ37877729-9E0932F5-361F-44CB-9F66-04A8C0B26C49Q37883723-AC320624-B605-4857-B65A-A79E75E4FD5EQ38020814-61299678-DF52-488B-BA85-A20C67888445Q38112176-D576354A-FA0B-4B3D-99A4-3BA1DABB44E6Q38800369-278BF465-6484-41C3-A9AE-E07625380DE3Q39389252-424950C4-56F1-40F4-92EC-C719409A990CQ41449149-69A7723E-A255-4C20-A6D3-64991DB19F46Q42141137-0D809679-63A5-483B-92EC-EAEFD3332CA1Q46448023-D20F1088-5F7C-4DA7-ADDC-035C5AF24FF5Q47886065-190995D9-F694-4FD0-B7EC-CAC0323B664FQ53080643-FAE2A427-1AA2-4CCF-B5F1-10F234A92207
P2860
Regulation of D-cyclin translation inhibition in myeloma cells treated with mammalian target of rapamycin inhibitors: rationale for combined treatment with extracellular signal-regulated kinase inhibitors and rapamycin.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Regulation of D-cyclin transla ...... nase inhibitors and rapamycin.
@en
Regulation of D-cyclin transla ...... nase inhibitors and rapamycin.
@nl
type
label
Regulation of D-cyclin transla ...... nase inhibitors and rapamycin.
@en
Regulation of D-cyclin transla ...... nase inhibitors and rapamycin.
@nl
prefLabel
Regulation of D-cyclin transla ...... nase inhibitors and rapamycin.
@en
Regulation of D-cyclin transla ...... nase inhibitors and rapamycin.
@nl
P2093
P2860
P1476
Regulation of D-cyclin transla ...... inase inhibitors and rapamycin
@en
P2093
Alan Lichtenstein
Yijiang Shi
P2860
P356
10.1158/1535-7163.MCT-08-0254
P577
2009-01-01T00:00:00Z